Wedge Capital Management L L P NC increased its holdings in LifeVantage Corp (NASDAQ:LFVN) by 17.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,426 shares of the company’s stock after acquiring an additional 15,719 shares during the period. Wedge Capital Management L L P NC owned about 0.74% of LifeVantage worth $1,431,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in LFVN. Acadian Asset Management LLC lifted its stake in LifeVantage by 14.7% in the second quarter. Acadian Asset Management LLC now owns 418,294 shares of the company’s stock valued at $5,430,000 after purchasing an additional 53,545 shares during the last quarter. BlackRock Inc. lifted its stake in LifeVantage by 237.4% in the second quarter. BlackRock Inc. now owns 891,174 shares of the company’s stock valued at $11,568,000 after purchasing an additional 627,070 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in LifeVantage by 21.6% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 46,104 shares of the company’s stock valued at $598,000 after purchasing an additional 8,175 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in LifeVantage by 214.7% in the second quarter. Jacobs Levy Equity Management Inc. now owns 117,545 shares of the company’s stock valued at $1,526,000 after purchasing an additional 80,199 shares during the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new position in LifeVantage in the second quarter valued at approximately $361,000. 41.30% of the stock is owned by institutional investors.
Separately, ValuEngine upgraded LifeVantage from a “strong sell” rating to a “sell” rating in a research note on Tuesday, October 29th.
LifeVantage stock traded down $0.24 during trading on Friday, hitting $14.59. The stock had a trading volume of 77,000 shares, compared to its average volume of 117,829. LifeVantage Corp has a 1 year low of $10.62 and a 1 year high of $17.08. The company has a quick ratio of 1.09, a current ratio of 1.67 and a debt-to-equity ratio of 0.02. The stock’s 50 day moving average is $14.20 and its two-hundred day moving average is $12.38. The stock has a market cap of $207.03 million, a price-to-earnings ratio of 24.73 and a beta of 0.61.
LifeVantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, October 30th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.01. The firm had revenue of $56.23 million for the quarter. LifeVantage had a return on equity of 38.13% and a net margin of 3.65%. As a group, equities research analysts anticipate that LifeVantage Corp will post 0.67 EPS for the current fiscal year.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Further Reading: S&P 500 Index
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.